Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.

B Vlaminckx, W van Pelt, L Schouls, A van Silfhout, C Elzenaar, E Mascini, J Verhoef, J Schellekens
Author Information
  1. B Vlaminckx: Eijkman Winkler Institute for Medical Microbiology, Infectious Diseases and Inflammation, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. b.j.m.vlaminckx@lab.azu.nl

Abstract

A prospective, nationwide, laboratory-based surveillance of invasive group A streptococcal infections was conducted in the Netherlands from 1992 through 1996. Clinical and demographic data were obtained and all isolates were T/M typed. All noninvasive group A streptococcal isolates were registered from 1994 through 1996. A total of 880 patients with invasive streptococcal disease were identified. The annual incidence was found to be 2.2 per 100,000. Predominant M types were M1 (21%), M3 (11%), M6 (5%), M12 (5%), and M28 (8%). Particular age and M-type distributions were observed in different clinical entities. The case-fatality rate was 18% overall, but it reached 59% among cases of toxic shock-like syndrome. Older age, necrotizing fasciitis, sepsis without focus, pneumonia, infection with type M1 or M3 strains, and underlying cardiopulmonary disease were associated with fatality. A total of 10,105 patients with noninvasive group A streptococcal disease were registered. These patients differed significantly from patients with invasive disease with regard to age distribution and primary foci of infection.

References

  1. J Exp Med. 1959 Aug 1;110(2):271-92 [PMID: 13673139]
  2. J Infect Dis. 1992 Aug;166(2):374-82 [PMID: 1634809]
  3. J Clin Microbiol. 1997 May;35(5):1231-5 [PMID: 9114412]
  4. JAMA. 1993 Jan 20;269(3):384-9 [PMID: 8418346]
  5. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668-72 [PMID: 1672766]
  6. J Infect Dis. 1991 Sep;164(3):595-8 [PMID: 1869845]
  7. N Engl J Med. 1996 Aug 22;335(8):547-54 [PMID: 8684408]
  8. Eur J Clin Microbiol Infect Dis. 1992 May;11(5):416-26 [PMID: 1425712]
  9. J Med Microbiol. 1993 Sep;39(3):165-78 [PMID: 8366514]
  10. J Infect Dis. 1994 Sep;170(3):585-91 [PMID: 8077715]
  11. Mol Microbiol. 1996 Jul;21(2):373-84 [PMID: 8858591]
  12. Scand J Infect Dis. 2000;32(4):377-84 [PMID: 10959645]
  13. Clin Infect Dis. 1998 Dec;27(6):1428-36 [PMID: 9868656]
  14. J Infect Dis. 1995 Apr;171(4):871-8 [PMID: 7706813]
  15. JAMA. 1993 Jan 20;269(3):390-1 [PMID: 8418347]
  16. N Engl J Med. 1987 Jul 16;317(3):146-9 [PMID: 3299086]
  17. Epidemiol Infect. 1988 Apr;100(2):257-69 [PMID: 3128449]
  18. Lancet. 1990 Nov 10;336(8724):1167-71 [PMID: 1978035]
  19. J Infect. 1988 Jan;16(1):37-46 [PMID: 3284952]
  20. J Infect. 1987 May;14(3):263-70 [PMID: 3295060]
  21. Pediatr Infect Dis J. 2003 Feb;22(2):105-9 [PMID: 12586971]
  22. Microb Pathog. 1994 Aug;17(2):111-20 [PMID: 7861955]
  23. J Infect Dis. 1994 Aug;170(2):368-76 [PMID: 8035023]
  24. Arch Intern Med. 2003 Feb 24;163(4):467-72 [PMID: 12588207]
  25. Infect Immun. 1999 Jun;67(6):2720-8 [PMID: 10338474]
  26. N Engl J Med. 1991 Sep 12;325(11):783-93 [PMID: 1870652]
  27. Infect Immun. 1999 Apr;67(4):1871-7 [PMID: 10085030]
  28. J Clin Microbiol. 2003 Mar;41(3):937-42 [PMID: 12624012]
  29. FEMS Microbiol Lett. 1994 Jun 1;119(1-2):19-25 [PMID: 8039659]
  30. J Clin Microbiol. 1991 Aug;29(8):1562-7 [PMID: 1684795]
  31. J Infect. 1993 Jul;27(1):83-8 [PMID: 8370953]
  32. Clin Infect Dis. 2002 Feb 15;34(4):454-60 [PMID: 11797171]
  33. J Infect Dis. 2002 Jun 1;185(11):1586-95 [PMID: 12023764]
  34. Pediatr Infect Dis J. 1991 Oct;10(10 Suppl):S20-4 [PMID: 1682872]
  35. J Infect Dis. 1997 Oct;176(4):992-1000 [PMID: 9333158]
  36. Scand J Infect Dis. 1990;22(4):421-9 [PMID: 2218404]
  37. J Infect Dis. 2000 Feb;181(2):631-8 [PMID: 10669348]
  38. Neth J Med. 1998 Jun;52(6):209-17 [PMID: 9718919]
  39. N Engl J Med. 2003 Apr 17;348(16):1546-54 [PMID: 12700374]
  40. FEMS Microbiol Lett. 1992 Dec 15;100(1-3):313-22 [PMID: 1478466]
  41. J Hyg (Lond). 1934 Dec;34(4):542-84 [PMID: 20475253]
  42. Clin Infect Dis. 2002 Aug 1;35(3):268-76 [PMID: 12115092]
  43. Adv Exp Med Biol. 1997;418:211-5 [PMID: 9331634]
  44. Rev Infect Dis. 1986 Nov-Dec;8(6):941-51 [PMID: 3541128]
  45. Scand J Infect Dis. 2000;32(6):609-14 [PMID: 11200369]
  46. MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(6):106-9 [PMID: 12645840]
  47. J Infect. 1995 Jul;31(1):33-7 [PMID: 8522829]
  48. Clin Infect Dis. 2002 Oct 15;35(8):950-9 [PMID: 12355382]

MeSH Term

Adolescent
Adult
Age Distribution
Aged
Analysis of Variance
Anti-Bacterial Agents
Bacteremia
Child
Child, Preschool
Drug Therapy, Combination
Fasciitis, Necrotizing
Female
Follow-Up Studies
Health Surveys
Humans
Incidence
Infant
Male
Middle Aged
Netherlands
Probability
Prospective Studies
Risk Assessment
Severity of Illness Index
Sex Distribution
Streptococcal Infections
Streptococcus pyogenes

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0streptococcaldiseaseinvasivegrouppatientsnoninvasiveageNetherlands1996isolatesregisteredtotal2M1M35%infectionprospectivenationwidelaboratory-basedsurveillanceinfectionsconducted1992ClinicaldemographicdataobtainedT/Mtyped1994880identifiedannualincidencefoundper100000PredominantMtypes21%11%M6M12M288%ParticularM-typedistributionsobserveddifferentclinicalentitiescase-fatalityrate18%overallreached59%amongcasestoxicshock-likesyndromeOldernecrotizingfasciitissepsiswithoutfocuspneumoniatypestrainsunderlyingcardiopulmonaryassociatedfatality10105differedsignificantlyregarddistributionprimaryfociEpidemiologicalfeatures1992-1996

Similar Articles

Cited By